Pancreatic cancer is known to have the lowest survival rate among all common cancers as most people with pancreatic cancer are diagnosed at a late stage. Researchers from the University of Oxford, UK, have identified 23 symptoms, including two new symptoms that will help in the early diagnosis of the common - pancreatic ductal adenocarcinoma (PDAC) and the rare - pancreatic neuroendocrine neoplasms (PNEN) type of pancreatic cancer.
This study is the largest of its kind and aims to aid in the early detection of PDCA and PNEN and improve the survival rate. Study design A cross-sectional study Data accessed from an electronic database of pancreatic cancer patients included in the study between 2000 to 2017 Symptoms of patients were observed at different time points before they were diagnosed with cancer and compared them with symptoms of other patients who were not diagnosed with…
